MarketCap
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
2019 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
40.8 M |
Marktkapitalisierung |
$ 2.36 B |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Jaguar Health
JAGX
|
$ 0.4 | -19.71 % | $ 933 K | Nasdaq Capital Market | USA |
 |
Arvinas
ARVN
|
$ 6.56 | -11.66 % | $ 465 M | Nasdaq Global Select Market,SPB | USA |
 |
Cerus Corporation
CERS
|
$ 2.13 | -12.01 % | $ 406 M | Nasdaq Global Market | USA |
 |
Beam Therapeutics
BEAM
|
$ 25.84 | -7.03 % | $ 2.56 B | Nasdaq Global Select Market | USA |
 |
Moderna
MRNA
|
$ 241.1 | -6.69 % | $ 93.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Fortress Biotech
FBIO
|
$ 1.83 | -7.11 % | $ 51.1 M | Nasdaq Capital Market | USA |
 |
Inhibrx
INBX
|
$ 80.4 | -7.34 % | $ 3.79 B | Nasdaq Global Select Market | USA |
 |
Entera Bio Ltd.
ENTX
|
$ 3.0 | -3.54 % | $ 139 M | Nasdaq Capital Market |  Israel |
 |
Flexion Therapeutics, Inc.
FLXN
|
- | - | $ 459 M | Nasdaq Global Market | USA |
 |
Legend Biotech Corporation
LEGN
|
$ 22.52 | -1.1 % | $ 8.3 B | Nasdaq Global Select Market | USA |
 |
CytomX Therapeutics
CTMX
|
$ 2.14 | -8.94 % | $ 295 M | Nasdaq Global Select Market | USA |
 |
Krystal Biotech
KRYS
|
$ 300.08 | -3.46 % | $ 8.69 B | Nasdaq Global Market,SPB | USA |
 |
Kura Oncology
KURA
|
$ 6.93 | -9.0 % | $ 608 M | Nasdaq Global Select Market | USA |
 |
Inhibikase Therapeutics
IKT
|
$ 1.45 | -7.67 % | $ 143 M | Nasdaq Capital Market | USA |
 |
Heron Therapeutics
HRTX
|
$ 0.28 | -6.8 % | $ 46.7 M | Nasdaq Global Select Market,SPB | USA |
 |
Inovio Pharmaceuticals
INO
|
$ 1.45 | -10.8 % | $ 68 M | Nasdaq Global Select Market | USA |
 |
Corvus Pharmaceuticals
CRVS
|
$ 9.73 | -7.95 % | $ 768 M | Nasdaq Global Market | USA |
 |
Aytu BioScience
AYTU
|
$ 1.83 | -4.69 % | $ 22.5 M | Nasdaq Capital Market | USA |
 |
Heat Biologics, Inc.
HTBX
|
- | -5.76 % | $ 99.8 M | Nasdaq Capital Market | USA |
 |
Innoviva
INVA
|
$ 19.23 | -9.57 % | $ 1.3 B | Nasdaq Global Select Market | USA |
 |
BioCardia
BCDA
|
$ 0.9 | -1.43 % | $ 6 M | Nasdaq Global Select Market | USA |
 |
Kindred Biosciences, Inc.
KIN
|
- | 0.11 % | $ 419 M | Nasdaq Global Select Market | USA |
 |
Alterity Therapeutics Limited
ATHE
|
$ 2.28 | -6.56 % | $ 14.6 B | Nasdaq Capital Market |  Australia |
 |
Shineco, Inc.
TYHT
|
- | -3.90 % | $ 97.2 M | Nasdaq Global Select Market |  China |
 |
Millendo Therapeutics, Inc.
MLND
|
- | -5.36 % | $ 20.2 M | Nasdaq Global Select Market | USA |
 |
Certara
CERT
|
$ 12.05 | 8.61 % | $ 1.93 B | Nasdaq Global Select Market | USA |
 |
Dyadic International
DYAI
|
$ 0.34 | -7.09 % | $ 12.3 M | Nasdaq Capital Market | USA |
 |
Intec Pharma Ltd
NTEC
|
- | -12.45 % | $ 17.7 M | Nasdaq Capital Market | Israel |
 |
Anika Therapeutics
ANIK
|
$ 19.29 | -5.44 % | $ 277 M | Nasdaq Global Select Market,SPB | USA |
 |
Aprea Therapeutics
APRE
|
$ 0.5 | -1.96 % | $ 3.27 M | Nasdaq Global Select Market,SPB | USA |
 |
Galectin Therapeutics
GALT
|
$ 2.98 | -14.12 % | $ 190 M | Nasdaq Global Select Market | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
$ 71.75 | -9.43 % | $ 7.45 B | Nasdaq Capital Market,SPB | USA |
 |
Progenity, Inc.
PROG
|
- | -3.47 % | $ 164 M | Nasdaq Global Select Market | USA |
 |
Genprex
GNPX
|
$ 2.09 | -2.34 % | $ 1.95 M | Nasdaq Capital Market | USA |
 |
Strongbridge Biopharma plc
SBBP
|
- | 1.52 % | $ 136 M | Nasdaq Global Select Market | USA |
 |
Innate Pharma S.A.
IPHA
|
$ 1.4 | -1.76 % | $ 125 M | Nasdaq Global Select Market |  France |
 |
Seneca Biopharma, Inc.
SNCA
|
- | -1.19 % | $ 28.7 M | Nasdaq Capital Market | USA |
 |
BioMarin Pharmaceutical
BMRN
|
$ 56.14 | -1.74 % | $ 10.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Matinas BioPharma Holdings
MTNB
|
$ 1.11 | -7.0 % | $ 6.08 M | NYSE American | USA |
 |
Enanta Pharmaceuticals
ENTA
|
$ 10.06 | -5.54 % | $ 215 K | Nasdaq Global Select Market,SPB | USA |
 |
Milestone Pharmaceuticals
MIST
|
$ 0.69 | -10.54 % | $ 73.3 M | Nasdaq Global Select Market |  Canada |
 |
Kiniksa Pharmaceuticals, Ltd.
KNSA
|
$ 88.15 | -8.29 % | $ 6.54 B | Nasdaq Global Select Market | USA |
 |
Lipocine
LPCN
|
$ 1.52 | 5.56 % | $ 8.28 M | Nasdaq Global Select Market | USA |
 |
Seres Therapeutics
MCRB
|
$ 2.09 | -2.63 % | $ 18.5 M | Nasdaq Global Select Market | USA |
 |
Madrigal Pharmaceuticals
MDGL
|
$ 400.26 | -0.04 % | $ 8.98 B | Nasdaq Global Select Market,SPB | USA |
 |
CEL-SCI Corporation
CVM
|
$ 1.35 | -2.88 % | $ 10.8 M | NYSE American,SPB | USA |
 |
Inventiva S.A.
IVA
|
$ 3.65 | -5.68 % | $ 218 M | Nasdaq Global Market | France |
 |
MeiraGTx Holdings plc
MGTX
|
$ 8.51 | -9.71 % | $ 684 M | Nasdaq Global Select Market | USA |
 |
Eton Pharmaceuticals
ETON
|
$ 47.29 | -6.76 % | $ 1.27 B | Nasdaq Global Market | USA |
 |
IDEAYA Biosciences
IDYA
|
$ 30.63 | -5.35 % | $ 2.71 B | Nasdaq Global Select Market | USA |